Huyabio International, Llc.

This early-stage study is testing a new oral medication called HBI-2376 in people with advanced solid tumors that have specific KRAS or EGFR mutations. The main goals are to find the highest safe dose of the drug and to understand how the body absorbs and processes it. The trial …

This is the first human study of an experimental oral medication called HBI-2438 for people with advanced solid tumors that have a specific genetic change called KRAS G12C. The main goals are to find the highest safe dose and understand how the body processes the drug. The study …

This large, late-stage trial is testing if adding an experimental oral drug called HBI-8000 to a standard immunotherapy (nivolumab) works better for controlling advanced skin cancer (melanoma) than the standard drug alone. It involves 450 adults and some adolescents with melanoma…

This study is testing a new drug called HBI-3000, given as a single 30-minute IV infusion, to see if it can safely and effectively restore a normal heart rhythm in people who have recently developed atrial fibrillation (AF). The trial has two parts: first, to find the best dose, …